These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37715443)

  • 1. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
    Zhong L; Qian W; Gong W; Zhu L; Wang X
    Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape.
    Wang W; Zhou Q; Lan L; Xu X
    Sci Rep; 2023 May; 13(1):8449. PubMed ID: 37231081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
    Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
    Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
    Zhuang L; Sun Q; Huang S; Hu L; Chen Q
    Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
    Song J; Xu Z; Fan Q; Sun Y; Lin X
    Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
    Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
    Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
    Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
    Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
    Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
    Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic of molecular subtypes based on PANoptosis-related genes and experimental verification of hepatocellular carcinoma.
    Ren H; Kang N; Yin S; Xu C; Qu T; Dai D
    Aging (Albany NY); 2023 May; 15(10):4159-4181. PubMed ID: 37171396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
    Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
    J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PANoptosis-related signature in melanoma: Transcriptomic mapping and clinical prognostication.
    Xie J; Zhang P; Xu X; Zhou X; Zhao S; Zhang M; Qi M
    Environ Toxicol; 2024 May; 39(5):2545-2559. PubMed ID: 38189554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PANoptosis: Emerging mechanisms and disease implications.
    Qi Z; Zhu L; Wang K; Wang N
    Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
    Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
    Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer.
    Mall R; Kanneganti TD
    Sci Rep; 2023 Nov; 13(1):20962. PubMed ID: 38017056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging single-cell sequencing analysis and bulk-RNA sequencing analysis to forecast necroptosis in cutaneous melanoma prognosis.
    Xie J; Zhang P; Tang Q; Ma C; Li M; Qi M
    Exp Dermatol; 2024 Jul; 33(7):e15148. PubMed ID: 39051739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell death shapes cancer immunity: spotlighting PANoptosis.
    Gao L; Shay C; Teng Y
    J Exp Clin Cancer Res; 2024 Jun; 43(1):168. PubMed ID: 38877579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Samir P; Malireddi RKS; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
    He P; Ma Y; Wu Y; Zhou Q; Du H
    Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.